Andrew Krug

Andrew Krug is an experienced manufacturing professional currently serving as the Manufacturing Manager at Cartesian Therapeutics since March 2024, after previously holding the role of Lead Manufacturing Associate. Prior to this, Andrew worked at MacroGenics, Inc. from March 2016 to March 2024 as a Senior Manufacturing Associate, where responsibilities included leading an upstream manufacturing team in CHO cell culture using stirred tank bioreactors. Andrew's career began at Trevigen, Inc., where from August 2013 to March 2016 as a Production Technician, duties involved creating various biochemical reagents and preparing products from stock solutions. Education includes ongoing studies at the University of Maryland following completion of high school at Loudoun Valley High School.